Drug
MOA
Indication
Discovery
Pre-Clinical
Phase 1
Notes
TriAx platform
ARB203
Bispecific TCE
GI cancers
ARB204
Bispecific TCE
Advanced GI cancers
ARB301
Tri-specific TCE
Advanced GI cancers
Antibody drug conjugate (ADC)
ADC001
Photosensitizer
Advanced GI caners
ADC002
Photo-caged photosensitizer
Advanced GI caners
ADC003
FDA-approved drug
Advanced GI caners
Cell Therapeutics
ARB001
CAR-T
mCRC
ARB011
CAR-NK/T
Advanced GI cancers
Diagnostic
Indication
Prototyping / Optimization
Validation
Clinical Trials
Launch
CDH17 - IHC Test
GI cancer diagnostics
CDH17 - Blood Test
CRC screening/surveillance
CDH17 - POCT
Pont-of-Care Test
